Suzette Glasner, Ph.D.
About Suzette Glasner, Ph.D.
Suzette Glasner, Ph.D., serves as the Chief Scientific Officer at Pelago, where she previously held the position of Vice President of Clinical Affairs. She is also an Associate Professor at the David Geffen School of Medicine at UCLA and has a strong background in psychology and clinical psychology.
Current Role at Pelago
Suzette Glasner, Ph.D., serves as the Chief Scientific Officer at Pelago, a position she has held since 2023. In this role, she oversees scientific initiatives and research strategies aimed at enhancing the effectiveness of Pelago's programs. Prior to this, she was the Vice President of Clinical Affairs at Pelago from 2020 to 2023, where she contributed to the development and implementation of clinical strategies.
Education and Expertise
Suzette Glasner earned her Bachelor of Arts in Psychology from UCLA, where she studied from 1994 to 1998. She then pursued a Ph.D. in Clinical Psychology at the University of Minnesota, completing her studies from 1998 to 2002. Her educational background provides a strong foundation for her work in clinical affairs and substance use care.
Professional Background
In addition to her roles at Pelago, Suzette Glasner has been an Associate Professor at the David Geffen School of Medicine at UCLA since 2007. With 17 years of experience in academia, she contributes to the field of clinical psychology through teaching and research. Her expertise includes managing legal, regulatory, and compliance aspects of substance use care.
Involvement in Adolescent Programs
Suzette Glasner is actively involved in extending Pelago's program to middle-adolescent dependents. This initiative aims to address substance use issues among younger populations, reflecting her commitment to improving health outcomes through targeted interventions.
Contributions to Health Outcomes
Suzette Glasner has been quoted discussing the transformative impact of Pelago's program on health outcomes and cost savings. Her insights highlight the effectiveness of the program in addressing substance use and improving overall health metrics.